Results 11 to 20 of about 7,425 (188)

Cabergoline therapy for Macroprolactinoma during pregnancy: A case report [PDF]

BMC Research Notes, 2012
Background We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. Case presentation We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia ...
Shahzad Hira, Sheikh Aisha, Sheikh Lumaan   +2 more
doaj   +2 more sources

Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients [PDF]

Gazi Medical Journal
Objective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology ...
Mehmet Muhittin Yalçın, Gizem Bedir Keser, Meriç Coşkun, Afruz Babayeva, Emrah Çeltikçi, Mehmet Arda İnan, Emetullah Cindil, Aylar Poyraz, Ethem Turgay Cerit, Alev Eroğlu Altınova, Müjde Aktürk, Füsun Baloş Törüner, Mehmet Ayhan Karakoç, İlhan Yetkin   +13 more
doaj   +2 more sources

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas [PDF]

Endocrinology and Metabolism, 2014
BackgroundCabergoline is typically effective for treating prolactinomas; however, some patients display cabergoline resistance, and the early characteristics of these patients remain unclear.
Youngki Lee, Cheol Ryong Ku, Eui-Hyun Kim, Jae Won Hong, Eun Jig Lee, Sun Ho Kim   +5 more
doaj   +3 more sources

Cabergoline-induced mania in a patient of pituitary microadenoma

Indian Journal of Psychological Medicine, 2017
Cabergoline, a dopamine agonist agent, is commonly used in the treatment of hyperprolactinemia, Parkinson's disease, restless leg syndrome, and antipsychotic-induced prolactin elevation.
Satyakam Mohapatra, Mihir Ranjan Nayak
doaj   +2 more sources

A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar

Therapeutics and Clinical Risk Management, 2016
Doua AlSaad,1 Samah ElSalem,1 Palli Valapila Abdulrouf,1 Binny Thomas,1,2 Tayseer Alsaad,3 Afif Ahmed,1 Moza AlHail4 1Department of Pharmacy, Women’s Hospital, Hamad Medical Corporation, Doha, Qatar; 2Department of Pharmacy and Life Sciences ...
AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M   +6 more
doaj   +1 more source

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline [PDF]

Case Reports in Endocrinology, 2013
Although advances in endocrinologic and neuroradiologic research allow easier recognition of pituitary adenomas, giant pituitary tumours are relatively rare.
Emre Bozkirli, Okan Bakiner, Emine Duygu Ersozlu Bozkirli, Eda Ertorer, Neslihan Bascil Tutuncu, Nilgun Guvener Demirag   +5 more
doaj   +2 more sources

Prolactinomas in the transition from adolescence to young adulthood: A multicentre, retrospective study from the TALENT group. [PDF]

J Neuroendocrinol
Abstract Prolactinomas in the transition age present unique challenges; treatment strategies and long‐term outcomes in this population remain incompletely characterised. This is a multicentre, retrospective study of 110 consecutive patients (33 males) with prolactinomas, aged 15–25 years, across five Italian referral centres (2010–2025).
De Alcubierre D, Giavoli C, Feola T, Cerroni L, Vincenzi L, Profka E, Pedroli A, Puliani G, Pirchio R, Tenuta M, Auriemma RS, Appetecchia ML, Pivonello R, Mantovani G, Isidori AM, Jaffrain-Rea ML, Grossman A, Sbardella E.   +17 more
europepmc   +2 more sources

Severe Hypernatraemia Secondary to Adipsia Associated With a Pituitary Macroadenoma in a Dog: A Case Report. [PDF]

Vet Med Sci
Severe hypernatraemia (Na+ 192 mmol/L) secondary to adipsia was successfully managed through gradual sodium correction, close monitoring and assisted water supplementation in a dog with a pituitary macroadenoma. No neurologic complications occurred during correction, and serum sodium concentrations remained stable for 9 months. This case highlights the
Choo GB, Choi BK, Choi S, Noh D, An JH.
europepmc   +2 more sources

Low-Dose Tadalafil and Cabergoline versus Cabergoline alone in Management of Erectile Dysfunction in Patients with End-Stage Renal Disease and Hyperprolactinemia Undergoing Hemodialysis [PDF]

Al-Azhar International Medical Journal
Background: Hyperprolactinemia in chronic kidney disease (CKD) is associated with high rates of hypogonadism and erectile dysfunction (ED). This study compares the efficacy, safety, and side effects of cabergoline monotherapy versus low-dose tadalafil ...
Elsayed Salih, Ali Abd ElMaqsood, Mohammed Elsalhy, Hazem Ayoub   +3 more
doaj   +1 more source

Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes

BMC Pharmacology and Toxicology, 2021
Background Dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia.
Mohammed Ahmed Fouad Shalaby, Hekma A. Abd El Latif, Mohamed El Yamani, May Ahmed Galal, Sherifa Kamal, Ikhlas Sindi, Raneem Masaood   +6 more
doaj   +1 more source